1.Multi-modal management of aggressive vertebral hemangioma: A single center experience
Mohamed FAROUK ; Mohamed Ali KASSEM ; Ashraf EZZELDEIN ; Mohamed Mohsen AMEEN ; Ali Hassan ELMOKADEM ; Mohamed M ELSHERBINI
Journal of Cerebrovascular and Endovascular Neurosurgery 2025;27(1):40-49
Objective:
This study aims at spotlighting different lines of management of aggressive vertebral hemangioma (VH) through a retrospective analysis of single center experience.
Methods:
Patients diagnosed with aggressive VHs in a tertiary referral center were reviewed from 2014 through 2024. Data of patients who met the inclusion criteria were analyzed. Patients of all ages, both sexes, and all varieties of clinical presentation were included, only patients who underwent at least one intervention were included.
Results:
The study included nine patients, comprising six females and three males, with a mean age of 29.3 years (ranging from 14 to 46). Six patients underwent Trans-arterial embolization (TAE), of whom five underwent further surgical procedures, while one patient found TAE to be sufficient as a stand-alone management technique. Eight patients underwent surgical management, five of whom were pre-operatively embolized.
Conclusions
Aggressive VHs are rare, and their management is challenging. Most cases require a multi-modal management, especially when presented with neurological deficit. Pre-operative embolization and/or vertebroplasty are safe and useful tools to decrease intra-operative bleeding of such a vascular pathology in cases undergoing open surgical procedures.
2.Multi-modal management of aggressive vertebral hemangioma: A single center experience
Mohamed FAROUK ; Mohamed Ali KASSEM ; Ashraf EZZELDEIN ; Mohamed Mohsen AMEEN ; Ali Hassan ELMOKADEM ; Mohamed M ELSHERBINI
Journal of Cerebrovascular and Endovascular Neurosurgery 2025;27(1):40-49
Objective:
This study aims at spotlighting different lines of management of aggressive vertebral hemangioma (VH) through a retrospective analysis of single center experience.
Methods:
Patients diagnosed with aggressive VHs in a tertiary referral center were reviewed from 2014 through 2024. Data of patients who met the inclusion criteria were analyzed. Patients of all ages, both sexes, and all varieties of clinical presentation were included, only patients who underwent at least one intervention were included.
Results:
The study included nine patients, comprising six females and three males, with a mean age of 29.3 years (ranging from 14 to 46). Six patients underwent Trans-arterial embolization (TAE), of whom five underwent further surgical procedures, while one patient found TAE to be sufficient as a stand-alone management technique. Eight patients underwent surgical management, five of whom were pre-operatively embolized.
Conclusions
Aggressive VHs are rare, and their management is challenging. Most cases require a multi-modal management, especially when presented with neurological deficit. Pre-operative embolization and/or vertebroplasty are safe and useful tools to decrease intra-operative bleeding of such a vascular pathology in cases undergoing open surgical procedures.
3.Multi-modal management of aggressive vertebral hemangioma: A single center experience
Mohamed FAROUK ; Mohamed Ali KASSEM ; Ashraf EZZELDEIN ; Mohamed Mohsen AMEEN ; Ali Hassan ELMOKADEM ; Mohamed M ELSHERBINI
Journal of Cerebrovascular and Endovascular Neurosurgery 2025;27(1):40-49
Objective:
This study aims at spotlighting different lines of management of aggressive vertebral hemangioma (VH) through a retrospective analysis of single center experience.
Methods:
Patients diagnosed with aggressive VHs in a tertiary referral center were reviewed from 2014 through 2024. Data of patients who met the inclusion criteria were analyzed. Patients of all ages, both sexes, and all varieties of clinical presentation were included, only patients who underwent at least one intervention were included.
Results:
The study included nine patients, comprising six females and three males, with a mean age of 29.3 years (ranging from 14 to 46). Six patients underwent Trans-arterial embolization (TAE), of whom five underwent further surgical procedures, while one patient found TAE to be sufficient as a stand-alone management technique. Eight patients underwent surgical management, five of whom were pre-operatively embolized.
Conclusions
Aggressive VHs are rare, and their management is challenging. Most cases require a multi-modal management, especially when presented with neurological deficit. Pre-operative embolization and/or vertebroplasty are safe and useful tools to decrease intra-operative bleeding of such a vascular pathology in cases undergoing open surgical procedures.
4.Construction of multi-epitope vaccine against the Rhipicephalus microplus tick: an immunoinformatics approach
Younas, M. ; Ashraf, K. ; Ijaz, M. ; Suleman, M. ; Chohan, T.A. ; Rahman, S.U. ; Rashid, M.I.
Tropical Biomedicine 2024;41(No.1):84-96
Rhipicephalus microplus, known as the hard tick, is a vector for the parasites Babesia spp. and
Anaplasma marginale, both of which can cause significant financial losses to the livestock industry.
There is currently no effective vaccine for R. microplus tick infestations, despite the identification of
numerous prospective tick vaccine candidates. As a result, the current research set out to develop
an immunoinformatics-based strategy using existing methods for designing a multi-epitope based
vaccination that is not only effective but also safe and capable of eliciting cellular and humoral immune
responses. First, R. microplus proteins Bm86, Subolesin, and Bm95 were used to anticipate and link B
and T-cell epitopes (HTL and CTL) to one another. Antigenicity testing, allergenicity assessment, and
toxicity screening were just a few of the many immunoinformatics techniques used to identify potent
epitopes. Multi-epitope vaccine design was chosen based on the antigenic score 0.935 that is promising
vaccine candidate. Molecular docking was used to determine the nature of the interaction between TLR2
and the vaccine construct. Finally, molecular dynamic simulation was used to assess the stability and
compactness of the resulting vaccination based on docking scores. The developed vaccine was shown
to be stable, have immunogenic qualities, be soluble, and to have high expression by in silico cloning.
These findings suggest that experimental investigation of the multi-epitope based vaccine designed in
the current study will produce achievable vaccine candidates against R. microplus ticks, enabling more
effective control of infestations.
5.Morphological and functional assessment of the left atrial appendage in daily practice:a comprehensive approach using basic and advanced echocardiography with practical tips
Journal of Cardiovascular Imaging 2024;32(1):12-
Cardioembolic stroke is the most serious and life-threatening complication of atrial fibrillation (AF), with an associated mortality up to 30% at 12 months. Approximately 47% of thrombi in valvular AF and 91% of thrombi in nonvalvular AF are localized in the left atrial appendage (LAA). Therefore, identification or exclusion of LAA thrombi is critical in many clinical situations. It is essential to assess LAA morphology and function using imaging modalities (particularly echocardiography) before, during, and after interventional procedures such as AF ablation and LAA occlusion. This review article describes the anatomical, physiological, and pathological background of the LAA, followed by an assessment of different echocardiographic modalities. Many practical points are included to improve the diagnostic accuracy and to minimize errors during image acquisition and interpretation. In each clinical scenario where LAA is the crucial target, specific and essential information and parameters are collected.
6.Global and regional cardiac magnetic resonance feature tracking left ventricular strain analysis in assessing early myocardial disease in β thalassemia major patients
Nihal M. BATOUTY ; Ahmad M. TAWFIK ; Donia M. SOBH ; Basma N. GADELHAK ; Shimaa EL‑ASHWAH ; Mohamed Abdelghafar HUSSEIN ; Mai GAD ; A. Ashraf Abd El AZIZ ; Mahmoud Abd EL‑SHAHED ; Rasha KARAM
Journal of Cardiovascular Imaging 2024;32(1):18-
Background:
Cardiac magnetic resonance imaging (CMR) is the modality of choice for quantification of myocardial iron overload in β-thalassemia major patients using the T2* sequence. CMR feature tracking (FT) is a recent magnetic resonance imaging tool that gives an idea about myocardial fibers deformation; thus, it can detect early impairment in myocardial function even before the reduction in ejection fraction.
Methods:
This study aims to assess the ability of left ventricular CMR-FT in the early detection of systolic dysfunction in β thalassemia major patients and to correlate it with the degree of myocardial iron overload measured by CMR T2*.This prospective study enrolled 57 β thalassemia major patients who received long-term blood transfusion and 20 healthy controls. CMR was used to evaluate left ventricular volumes, ejection fraction, and the amount of myocardial T2*. A two-dimensional left ventricular FT analysis was performed. Both global and segmental left ventricular strain values were obtained.
Results:
The mean global circumferential strain (GCS) and global radial strain (GRS) values were significantly lower in patients compared to control (P = 0.002 and P = 0.006, respectively). No correlation was found between T2* values and ejection fraction; however, there was a significant correlation between T2* values and GCS and GRS (P = 0.012 and P = 0.025, respectively) in thalassemia patients. Regional strain revealed significantly lower values of GCS and GRS in basal regions compared to apical ones (P = 0.000).
Conclusions
Our study revealed that CMR-FT can play a role in the early detection of systolic impairment in thalas‑ semia patients.
7.Molecular prevalence of Anaplasma marginale in ruminants and Rhipicephalus ticks in northern Pakistan
Ali, S. ; Hasan, M. ; Ahmad, A.S. ; Ashraf, K. ; Khan, J.A. ; Rashid, M.I.
Tropical Biomedicine 2023;40(No.1):7-13
Anaplasma marginale is the most prevalent tick-borne haemoparasite of cattle and causes huge
economic losses to the dairy industry worldwide. This study aimed to determine the occurrence of A.
marginale infection in blood and tick samples collected from livestock animals in the districts located
in Khyber Pakhtunkhwa (KPK), Pakistan. A total of 184 blood and 370 tick samples were included in this
study. It has never been reported that sheep, goats, and cattle in Tank, Ghulam Khan, Birmil and Miran
Shah areas were infected with A. marginale. All samples of blood and ticks were collected through
random sampling from March 2021 to January 2022 from cattle, sheep and goats and screened through
PCR for anaplasmosis by using primer pairs of Anaplasma spp. Three hundred and seventy ticks were
collected from infested hosts (120/184, 64.21%). Among the four morphologically identified tick species,
the highest occurrence was recorded for Rhipicephalus sanguineus (n=138, 37.29%), followed by
Rhipicephalus microplus (n=131, 35.4%), Rhipicephalus annulatus (n=40, 10.81%), Hyalomma anatolicum
(n=31, 8.37%), and Hyalomma marginatum (n=30, 8.1%). The occurrence of female tick was highest
(n=160, 43.24%), followed by nymphs (n=140, 37.38%) and males ticks (n=70, 18.9%). Among these ticks,
A. marginale was detected in female ticks of R. microplus, and R. sanguineus. Molecular identification
of A. marginale was confirmed in 120 out of 184 blood samples and 6 out of 74 tick samples. Overall,
occurrence of A. marginale in blood and tick samples was found to be 65.21% and 8.1% respectively.
Species-wise occurrence in blood samples of goats were 71.11% followed by sheep 68.31% and cattle
50%. Specie-wise occurrence of A. marginale in tick samples of cattle were 12.5% followed by goats
6.89%. The obtained sequence showed similarity with A. marginale reported from Kenya and USA. We
report the first PCR based detection of A. marginale infection in blood samples and in R. sanguineus
ticks of goats simultaneously.
8.Antimicrobial activity of essential oils of Curcuma longa and Syzygium aromaticum against multiple drug-resistant pathogenic bacteria
Zeshan, M.Q. ; Ashraf, M. ; Omer, M.O. ; Anjum, A.A. ; Ali, M.A. ; Najeeb, M. ; Majeed, J.
Tropical Biomedicine 2023;40(No.2):174-182
The present study was conducted to investigate the antimicrobial potential of essential oils of Curcuma
longa and Syzygium aromaticum against multidrug-resistant pathogenic bacteria. Four identified
bacterial isolates including Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Klebsiella
pneumoniae, and Acinetobacter baumannii were selected and their antibiotic sensitivity was checked
by disc diffusion assay. C. longa and S. aromaticum were subjected to steam distillation to obtain their
essential oils. The crude essential oils were fractioned by employing column chromatography. Crude
essential oils and their fractions were evaluated for their antibacterial activity by agar well diffusion
assay and minimum inhibitory concentrations were calculated. All the selected bacterial isolates
showed resistance to three or more than three antibiotic groups and were declared as multidrugresistant (MDRs). Crude essential oils of C. longa and S. aromaticum exhibited antimicrobial activity
against all selected isolates but S. aromaticum activity was better than the C. longa with a maximum
19.3±1.50 mm zone of inhibition against A. baumannii at 1.04 µL/mL MIC. GC/MS analysis revealed
the abundance of components including eugenol, eugenyl acetate, b- caryophyllene, and a- Humulene
in both crude oil and fractions of S. aromaticum. While the main components of C. longa essential oil
were Ar-tumerone, a–tumerone, b- Tumerone, I-Phellandrene, a-zingibirene, b- sesquiphellandrene,
and p- Cymene. This study highlights that plant-based essential oils could be a promising alternative to
antibiotics for which pathogens have developed resistance. C. longa and S. aromaticum carry compounds
that have antimicrobial potential against multiple drug-resistant bacteria including MRSA. E. coli, K.
pneumoniae and A. baumannii.
9.Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation.
Ashraf DUZAN ; Desiree REINKEN ; Timothy L MCGOMERY ; Nicholas M FERENCZ ; Jacob M PLUMMER ; Mufeed M BASTI
Journal of Integrative Medicine 2023;21(2):120-129
Globally, it is evident that glioblastoma multiforme (GBM) is an aggressive malignant cancer with a high mortality rate and no effective treatment options. Glioblastoma is classified as the stage-four progression of a glioma tumor, and its diagnosis results in a shortened life expectancy. Treatment options for GBM include chemotherapy, immunotherapy, surgical intervention, and conventional pharmacotherapy; however, at best, they extend the patient's life by a maximum of 5 years. GBMs are considered incurable due to their high recurrence rate, despite various aggressive therapeutic approaches which can have many serious adverse effects. Ceramides, classified as endocannabinoids, offer a promising novel therapeutic approach for GBM. Endocannabinoids may enhance the apoptosis of GBM cells but have no effect on normal healthy neural cells. Cannabinoids promote atypical protein kinase C, deactivate fatty acid amide hydrolase enzymes, and activate transient receptor potential vanilloid 1 (TRPV1) and TRPV2 to induce pro-apoptotic signaling pathways without increasing endogenous cannabinoids. In previous in vivo studies, endocannabinoids, chemically classified as amide formations of oleic and palmitic acids, have been shown to increase the pro-apoptotic activity of human cancer cells and inhibit cell migration and angiogenesis. This review focuses on the biological synthesis and pharmacology of endogenous cannabinoids for the enhancement of cancer cell apoptosis, which have potential as a novel therapy for GBM. Please cite this article as: Duzan A, Reinken D, McGomery TL, Ferencz N, Plummer JM, Basti MM. Endocannabinoids are potential inhibitors of glioblastoma multiforme proliferation. J Integr Med. 2023; 21(2): 120-128.
Humans
;
Glioblastoma/pathology*
;
Endocannabinoids/therapeutic use*
;
Brain Neoplasms/pathology*
;
Cell Proliferation
;
Cell Line, Tumor
;
Cannabinoids/therapeutic use*
10.Burden of Early Life Obesity and Its Relationship with Protein Intake in Infancy: The Middle East Expert Consensus
Frank JOCHUM ; Mohamed ABDELLATIF ; Ashraf ADEL ; Ahmed ALHAMMADI ; Abdulrahman ALNEMRI ; Eman ALOHALI ; Khaled ALSARRAF ; Khoula AL SAID ; Mahmoud ELZALABANY ; Hasan M. A. ISA ; Sridhar KALYANASUNDARAM ; Naguib Abdel REHEIM ; Omar SAADAH
Pediatric Gastroenterology, Hepatology & Nutrition 2022;25(2):93-108
Adequate nutrition in early life is proposed to shape a child’s future health by launching the growth trajectory in the proper direction, which helps to avoid negative metabolic programming effects. Protein intake during infancy and early childhood is of great importance, as it plays a key role in infant metabolic programming and the future risk of obesity. Breastfeeding provides the best nutrition in early life, with many benefits tailored for the baby, including the appropriate quantity and quality of proteins. Considering the high prevalence of childhood, and subsequent adult, obesity in the region, a virtual Middle East expert consensus meeting was held to discuss an effective approach for managing childhood obesity. Leading pediatric experts from Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates participated in the meeting. The experts discussed, debated, and agreed on certain directions, including the importance of educating parents, endorsing breastfeeding, and ensuring optimum quantity and quality intake of proteins in early life.This expert consensus may serve as the starting point for healthcare professionals in the region who are interested in shaping a healthy future for the generations to come.


Result Analysis
Print
Save
E-mail